Corvus (CRVS) Q3 2026 Earnings Call Transcript
Soquelitinib's expanding pipeline spans lymphoma, eczema, skin disease and asthma.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Natera (NTRA) Q3 2026 Earnings Call Transcript
Natera's new CEO outlines a path to double revenue by 2029
Elon Musk's Tesla to 'wind down' Cybertruck production next year
Musk said the decision was taken in order to make room for increased production of its Cybercab robotaxi. The move comes after years of weaker-than-expected sales for the futuristic electric pickup.
DENTSPLY (XRAY) Q3 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
Rupee strengthens to close at a six-and-a-half-month high
The Indian currency closed at 93.90 per USD, up 57 paise against the previous close of 94.47
Sera Prognostics (SERA) Q3 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
Interactive Brokers Group Moves Up In Analyst Rankings, Passing Edwards Lifesciences
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Interactive Brokers Group Inc - Class A (Symbol: IBKR) has taken over the #62 spot from…